Effect of the mineralocorticoid receptor antagonist eplerenone on liver fat and metabolism in patients with type 2 diabetes: A randomized, double‐blind, placebo‐controlled trial (MIRAD trial)
出版年份 2019 全文链接
标题
Effect of the mineralocorticoid receptor antagonist eplerenone on liver fat and metabolism in patients with type 2 diabetes: A randomized, double‐blind, placebo‐controlled trial (MIRAD trial)
作者
关键词
-
出版物
DIABETES OBESITY & METABOLISM
Volume -, Issue -, Pages -
出版商
Wiley
发表日期
2019-06-11
DOI
10.1111/dom.13809
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- Effect of Empagliflozin on Liver Fat in Patients With Type 2 Diabetes and Nonalcoholic Fatty Liver Disease: A Randomized Controlled Trial (E-LIFT Trial)
- (2018) Mohammad Shafi Kuchay et al. DIABETES CARE
- European Association for the Study of the Liver (EASL), European Association for the Study of Diabetes (EASD) and European Association for the Study of Obesity (EASO) clinical practice recommendations for the management of non-alcoholic fatty liver diseas
- (2018) A. L. Sberna et al. DIABETIC MEDICINE
- Serum potassium and adverse outcomes across the range of kidney function: a CKD Prognosis Consortium meta-analysis
- (2018) Csaba P Kovesdy et al. EUROPEAN HEART JOURNAL
- Cardiovascular events and target organ damage in primary aldosteronism compared with essential hypertension: a systematic review and meta-analysis
- (2018) Silvia Monticone et al. Lancet Diabetes & Endocrinology
- Mineralocorticoid Antagonism Enhances Brown Adipose Tissue Function In Humans: A Randomized Placebo-controlled Cross-over Study
- (2018) Moe Thuzar et al. DIABETES OBESITY & METABOLISM
- Effect of eplerenone in patients with heart failure and reduced ejection fraction: potential effect modification by abdominal obesity. Insight from the EMPHASIS-HF trial
- (2017) Arnaud Olivier et al. EUROPEAN JOURNAL OF HEART FAILURE
- The diagnosis and management of nonalcoholic fatty liver disease: Practice guidance from the American Association for the Study of Liver Diseases
- (2017) Naga Chalasani et al. HEPATOLOGY
- Metabolic and histological implications of intrahepatic triglyceride content in nonalcoholic fatty liver disease
- (2017) Fernando Bril et al. HEPATOLOGY
- Preventive and chronic mineralocorticoid receptor antagonism is highly beneficial in obese SHHF rats
- (2016) G Youcef et al. BRITISH JOURNAL OF PHARMACOLOGY
- Adipocyte-Specific Mineralocorticoid Receptor Overexpression in Mice Is Associated With Metabolic Syndrome and Vascular Dysfunction: Role of Redox-Sensitive PKG-1 and Rho Kinase
- (2016) Aurelie Nguyen Dinh Cat et al. DIABETES
- Fibrosis Assessment in Nonalcoholic Fatty Liver Disease (NAFLD) in 2016
- (2016) Dharmesh H. Kaswala et al. DIGESTIVE DISEASES AND SCIENCES
- EASL–EASD–EASO Clinical Practice Guidelines for the management of non-alcoholic fatty liver disease
- (2016) JOURNAL OF HEPATOLOGY
- Liraglutide safety and efficacy in patients with non-alcoholic steatohepatitis (LEAN): a multicentre, double-blind, randomised, placebo-controlled phase 2 study
- (2016) Matthew James Armstrong et al. LANCET
- Renin-Angiotensin System Inhibitors, Type 2 Diabetes and Fibrosis Progression: An Observational Study in Patients with Nonalcoholic Fatty Liver Disease
- (2016) Serena Pelusi et al. PLoS One
- Adipocyte Mineralocorticoid Receptor Activation Leads to Metabolic Syndrome and Induction of Prostaglandin D2 SynthaseNovelty and Significance
- (2015) Riccardo Urbanet et al. HYPERTENSION
- Beneficial effects of mineralocorticoid receptor blockade in experimental non-alcoholic steatohepatitis
- (2015) Margarita Pizarro et al. LIVER INTERNATIONAL
- Aldosterone Predicts Cardiovascular, Renal, and Metabolic Disease in the General Community: A 4‐Year Follow‐Up
- (2015) Alessia Buglioni et al. Journal of the American Heart Association
- Mineralocorticoid receptor antagonism induces browning of white adipose tissue through impairment of autophagy and prevents adipocyte dysfunction in high-fat-diet-fed mice
- (2014) Andrea Armani et al. FASEB JOURNAL
- Eplerenone ameliorates the phenotypes of metabolic syndrome with NASH in liver-specific SREBP-1c Tg mice fed high-fat and high-fructose diet
- (2013) Tsutomu Wada et al. AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM
- Narrative Review: The Emerging Clinical Implications of the Role of Aldosterone in the Metabolic Syndrome and Resistant Hypertension
- (2013) James R. Sowers ANNALS OF INTERNAL MEDICINE
- Mineralocorticoid Receptor-Mediated Vascular Insulin Resistance: An Early Contributor to Diabetes-Related Vascular Disease?
- (2013) S. B. Bender et al. DIABETES
- Differential Associations of Oral Glucose Tolerance Test–Derived Measures of Insulin Sensitivity and Pancreatic β-Cell Function With Coronary Artery Calcification and Microalbuminuria in Type 2 Diabetes
- (2013) Claire K. Mulvey et al. DIABETES CARE
- Effect of mineralocorticoid receptor antagonist on insulin resistance and endothelial function in obese subjects
- (2013) R. Garg et al. DIABETES OBESITY & METABOLISM
- ESC Guidelines on diabetes, pre-diabetes, and cardiovascular diseases developed in collaboration with the EASD
- (2013) EUROPEAN HEART JOURNAL
- Effects of canrenone in patients with metabolic syndrome
- (2013) Giuseppe Derosa et al. EXPERT OPINION ON PHARMACOTHERAPY
- Fibrosis and cardiac function in obesity: a randomised controlled trial of aldosterone blockade
- (2013) Wojciech Kosmala et al. HEART
- Effect of colesevelam on liver fat quantified by magnetic resonance in nonalcoholic steatohepatitis: A randomized controlled trial
- (2012) Thuy-Anh Le et al. HEPATOLOGY
- Effect of low dose mineralocorticoid receptor antagonist eplerenone on glucose and lipid metabolism in healthy adult males
- (2012) Alexander W. Krug et al. METABOLISM-CLINICAL AND EXPERIMENTAL
- Aldosterone decreases glucose-stimulated insulin secretion in vivo in mice and in murine islets
- (2011) J. M. Luther et al. DIABETOLOGIA
- Association of plasma aldosterone with the metabolic syndrome in two German populations
- (2011) Anke Hannemann et al. EUROPEAN JOURNAL OF ENDOCRINOLOGY
- MR spectroscopy of liver in overweight children and adolescents: Investigation of 1H T2 relaxation times at 3T
- (2011) Elizaveta Chabanova et al. EUROPEAN JOURNAL OF RADIOLOGY
- Spironolactone Improves Glucose and Lipid Metabolism by Ameliorating Hepatic Steatosis and Inflammation and Suppressing Enhanced Gluconeogenesis Induced by High-Fat and High-Fructose Diet
- (2010) Tsutomu Wada et al. ENDOCRINOLOGY
- Risk of Cardiovascular Disease in Patients with Nonalcoholic Fatty Liver Disease
- (2010) Giovanni Targher et al. NEW ENGLAND JOURNAL OF MEDICINE
- Mineralocorticoid Receptor Blockade Reverses Obesity-Related Changes in Expression of Adiponectin, Peroxisome Proliferator-Activated Receptor-γ, and Proinflammatory Adipokines
- (2008) Christine Guo et al. CIRCULATION
- Eplerenone improves prognosis in postmyocardial infarction diabetic patients with heart failure: results from EPHESUS
- (2007) J. H. O’Keefe et al. DIABETES OBESITY & METABOLISM
Become a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get StartedAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started